{"id":794718,"date":"2024-12-12T17:03:21","date_gmt":"2024-12-12T22:03:21","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/onconetix-inc-announces-receipt-of-notice-from-nasdaq-regarding-late-filing-of-quarterly-report-on-form-10-q-and-subsequent-filing\/"},"modified":"2024-12-12T17:03:21","modified_gmt":"2024-12-12T22:03:21","slug":"onconetix-inc-announces-receipt-of-notice-from-nasdaq-regarding-late-filing-of-quarterly-report-on-form-10-q-and-subsequent-filing","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/onconetix-inc-announces-receipt-of-notice-from-nasdaq-regarding-late-filing-of-quarterly-report-on-form-10-q-and-subsequent-filing\/","title":{"rendered":"Onconetix, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q and Subsequent Filing"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">Cincinnati, OH, Dec.  12, 2024  (GLOBE NEWSWIRE) &#8212; Onconetix, Inc. (NASDAQ: ONCO) (the \u201cCompany\u201d) announced that it received a letter from The Nasdaq Capital Market (\u201cNasdaq\u201d) on December 6, 2024 indicating that the Company\u2019s failure to file its Quarterly Report on Form 10-Q for the period ended September 30, 2024 (the \u201cForm 10-Q\u201d) is in violation of Nasdaq\u2019s continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the \u201cRule\u201d).<\/p>\n<p align=\"justify\">On December 10, 2024, the Company filed the Form 10-Q with the Securities and Exchange Commission.\u00a0\u00a0<\/p>\n<p align=\"justify\">This announcement is made in compliance with Nasdaq Listing Rule 5810(b), which requires prompt disclosure of receipt of a deficiency notification.\u00a0\u00a0<\/p>\n<p align=\"justify\">About Onconetix, Inc.:<\/p>\n<p>Onconetix is a commercial stage biotechnology company focused on the research, development and commercialization of innovative solutions for men\u2019s health and oncology. Through our recent acquisition of Proteomedix, we own Proclarix\u00ae, an in vitro diagnostic test for prostate cancer originally developed by Proteomedix and approved for sale in the European Union (\u201cEU\u201d) under the In Vitro Diagnostic Regulation (\u201cIVDR\u201d). We also own ENTADFI, an FDA-approved, once daily pill that combines finasteride and tadalafil for the treatment of benign prostatic hyperplasia (\u201cBPH\u201d), a disorder of the prostate. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=swliGfTfeNUOK_tl3C-3_85t62FmzOA_PUFhLz3NpCzjxQGdMgn8KJmUbQV-kUwj8W4N_PZnhLw5ZJHVX2JX5MbLXov4uxXPXBSrCYurHqo=\" rel=\"nofollow\" target=\"_blank\">www.onconetix.com<\/a>.<\/p>\n<p>Contact Information:<\/p>\n<p align=\"justify\">Onconetix, Inc.<br \/>201 E. Fifth Street, Suite 1900<br \/>Cincinnati, OH 45202<br \/>Phone: (513) 620-4101<\/p>\n<p>\n        <b>Investor Contact Information:<\/b>\n      <\/p>\n<p>Onconetix Investor Relations<br \/>Email: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=TcTIb6b5UZWzprFvjmlMvsy3m1guR1avydVhBi9tjGP4glPRw_5bo91l5kzj-s7WqrdRB8n2nzuJ24oka75lxezMk3vqROZb3J9AJ9W8whA=\" rel=\"nofollow\" target=\"_blank\">investors@onconetix.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxODcxNyM2NjM1OTIyIzUwMDEyNjMzNw==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MmQzMGY0MzMtM2M1ZS00NDI3LTgxNDYtYjU0NjU3NTUxNTU5LTUwMDEyNjMzNw==\/tiny\/Onconetix-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Cincinnati, OH, Dec. 12, 2024 (GLOBE NEWSWIRE) &#8212; Onconetix, Inc. (NASDAQ: ONCO) (the \u201cCompany\u201d) announced that it received a letter from The Nasdaq Capital Market (\u201cNasdaq\u201d) on December 6, 2024 indicating that the Company\u2019s failure to file its Quarterly Report on Form 10-Q for the period ended September 30, 2024 (the \u201cForm 10-Q\u201d) is in violation of Nasdaq\u2019s continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the \u201cRule\u201d). On December 10, 2024, the Company filed the Form 10-Q with the Securities and Exchange Commission.\u00a0\u00a0 This announcement is made in compliance with Nasdaq Listing Rule 5810(b), which requires prompt disclosure of receipt of a deficiency notification.\u00a0\u00a0 About Onconetix, Inc.: Onconetix is a commercial stage biotechnology company focused on the research, development &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/onconetix-inc-announces-receipt-of-notice-from-nasdaq-regarding-late-filing-of-quarterly-report-on-form-10-q-and-subsequent-filing\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Onconetix, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q and Subsequent Filing&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-794718","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Onconetix, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q and Subsequent Filing - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/onconetix-inc-announces-receipt-of-notice-from-nasdaq-regarding-late-filing-of-quarterly-report-on-form-10-q-and-subsequent-filing\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Onconetix, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q and Subsequent Filing - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Cincinnati, OH, Dec. 12, 2024 (GLOBE NEWSWIRE) &#8212; Onconetix, Inc. (NASDAQ: ONCO) (the \u201cCompany\u201d) announced that it received a letter from The Nasdaq Capital Market (\u201cNasdaq\u201d) on December 6, 2024 indicating that the Company\u2019s failure to file its Quarterly Report on Form 10-Q for the period ended September 30, 2024 (the \u201cForm 10-Q\u201d) is in violation of Nasdaq\u2019s continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the \u201cRule\u201d). On December 10, 2024, the Company filed the Form 10-Q with the Securities and Exchange Commission.\u00a0\u00a0 This announcement is made in compliance with Nasdaq Listing Rule 5810(b), which requires prompt disclosure of receipt of a deficiency notification.\u00a0\u00a0 About Onconetix, Inc.: Onconetix is a commercial stage biotechnology company focused on the research, development &hellip; Continue reading &quot;Onconetix, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q and Subsequent Filing&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/onconetix-inc-announces-receipt-of-notice-from-nasdaq-regarding-late-filing-of-quarterly-report-on-form-10-q-and-subsequent-filing\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-12T22:03:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxODcxNyM2NjM1OTIyIzUwMDEyNjMzNw==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/onconetix-inc-announces-receipt-of-notice-from-nasdaq-regarding-late-filing-of-quarterly-report-on-form-10-q-and-subsequent-filing\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/onconetix-inc-announces-receipt-of-notice-from-nasdaq-regarding-late-filing-of-quarterly-report-on-form-10-q-and-subsequent-filing\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Onconetix, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q and Subsequent Filing\",\"datePublished\":\"2024-12-12T22:03:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/onconetix-inc-announces-receipt-of-notice-from-nasdaq-regarding-late-filing-of-quarterly-report-on-form-10-q-and-subsequent-filing\\\/\"},\"wordCount\":237,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/onconetix-inc-announces-receipt-of-notice-from-nasdaq-regarding-late-filing-of-quarterly-report-on-form-10-q-and-subsequent-filing\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMxODcxNyM2NjM1OTIyIzUwMDEyNjMzNw==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/onconetix-inc-announces-receipt-of-notice-from-nasdaq-regarding-late-filing-of-quarterly-report-on-form-10-q-and-subsequent-filing\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/onconetix-inc-announces-receipt-of-notice-from-nasdaq-regarding-late-filing-of-quarterly-report-on-form-10-q-and-subsequent-filing\\\/\",\"name\":\"Onconetix, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q and Subsequent Filing - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/onconetix-inc-announces-receipt-of-notice-from-nasdaq-regarding-late-filing-of-quarterly-report-on-form-10-q-and-subsequent-filing\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/onconetix-inc-announces-receipt-of-notice-from-nasdaq-regarding-late-filing-of-quarterly-report-on-form-10-q-and-subsequent-filing\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMxODcxNyM2NjM1OTIyIzUwMDEyNjMzNw==\",\"datePublished\":\"2024-12-12T22:03:21+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/onconetix-inc-announces-receipt-of-notice-from-nasdaq-regarding-late-filing-of-quarterly-report-on-form-10-q-and-subsequent-filing\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/onconetix-inc-announces-receipt-of-notice-from-nasdaq-regarding-late-filing-of-quarterly-report-on-form-10-q-and-subsequent-filing\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/onconetix-inc-announces-receipt-of-notice-from-nasdaq-regarding-late-filing-of-quarterly-report-on-form-10-q-and-subsequent-filing\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMxODcxNyM2NjM1OTIyIzUwMDEyNjMzNw==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMxODcxNyM2NjM1OTIyIzUwMDEyNjMzNw==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/onconetix-inc-announces-receipt-of-notice-from-nasdaq-regarding-late-filing-of-quarterly-report-on-form-10-q-and-subsequent-filing\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Onconetix, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q and Subsequent Filing\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Onconetix, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q and Subsequent Filing - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/onconetix-inc-announces-receipt-of-notice-from-nasdaq-regarding-late-filing-of-quarterly-report-on-form-10-q-and-subsequent-filing\/","og_locale":"en_US","og_type":"article","og_title":"Onconetix, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q and Subsequent Filing - Market Newsdesk","og_description":"Cincinnati, OH, Dec. 12, 2024 (GLOBE NEWSWIRE) &#8212; Onconetix, Inc. (NASDAQ: ONCO) (the \u201cCompany\u201d) announced that it received a letter from The Nasdaq Capital Market (\u201cNasdaq\u201d) on December 6, 2024 indicating that the Company\u2019s failure to file its Quarterly Report on Form 10-Q for the period ended September 30, 2024 (the \u201cForm 10-Q\u201d) is in violation of Nasdaq\u2019s continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the \u201cRule\u201d). On December 10, 2024, the Company filed the Form 10-Q with the Securities and Exchange Commission.\u00a0\u00a0 This announcement is made in compliance with Nasdaq Listing Rule 5810(b), which requires prompt disclosure of receipt of a deficiency notification.\u00a0\u00a0 About Onconetix, Inc.: Onconetix is a commercial stage biotechnology company focused on the research, development &hellip; Continue reading \"Onconetix, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q and Subsequent Filing\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/onconetix-inc-announces-receipt-of-notice-from-nasdaq-regarding-late-filing-of-quarterly-report-on-form-10-q-and-subsequent-filing\/","og_site_name":"Market Newsdesk","article_published_time":"2024-12-12T22:03:21+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxODcxNyM2NjM1OTIyIzUwMDEyNjMzNw==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/onconetix-inc-announces-receipt-of-notice-from-nasdaq-regarding-late-filing-of-quarterly-report-on-form-10-q-and-subsequent-filing\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/onconetix-inc-announces-receipt-of-notice-from-nasdaq-regarding-late-filing-of-quarterly-report-on-form-10-q-and-subsequent-filing\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Onconetix, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q and Subsequent Filing","datePublished":"2024-12-12T22:03:21+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/onconetix-inc-announces-receipt-of-notice-from-nasdaq-regarding-late-filing-of-quarterly-report-on-form-10-q-and-subsequent-filing\/"},"wordCount":237,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/onconetix-inc-announces-receipt-of-notice-from-nasdaq-regarding-late-filing-of-quarterly-report-on-form-10-q-and-subsequent-filing\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxODcxNyM2NjM1OTIyIzUwMDEyNjMzNw==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/onconetix-inc-announces-receipt-of-notice-from-nasdaq-regarding-late-filing-of-quarterly-report-on-form-10-q-and-subsequent-filing\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/onconetix-inc-announces-receipt-of-notice-from-nasdaq-regarding-late-filing-of-quarterly-report-on-form-10-q-and-subsequent-filing\/","name":"Onconetix, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q and Subsequent Filing - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/onconetix-inc-announces-receipt-of-notice-from-nasdaq-regarding-late-filing-of-quarterly-report-on-form-10-q-and-subsequent-filing\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/onconetix-inc-announces-receipt-of-notice-from-nasdaq-regarding-late-filing-of-quarterly-report-on-form-10-q-and-subsequent-filing\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxODcxNyM2NjM1OTIyIzUwMDEyNjMzNw==","datePublished":"2024-12-12T22:03:21+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/onconetix-inc-announces-receipt-of-notice-from-nasdaq-regarding-late-filing-of-quarterly-report-on-form-10-q-and-subsequent-filing\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/onconetix-inc-announces-receipt-of-notice-from-nasdaq-regarding-late-filing-of-quarterly-report-on-form-10-q-and-subsequent-filing\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/onconetix-inc-announces-receipt-of-notice-from-nasdaq-regarding-late-filing-of-quarterly-report-on-form-10-q-and-subsequent-filing\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxODcxNyM2NjM1OTIyIzUwMDEyNjMzNw==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxODcxNyM2NjM1OTIyIzUwMDEyNjMzNw=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/onconetix-inc-announces-receipt-of-notice-from-nasdaq-regarding-late-filing-of-quarterly-report-on-form-10-q-and-subsequent-filing\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Onconetix, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q and Subsequent Filing"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/794718","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=794718"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/794718\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=794718"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=794718"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=794718"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}